Kaveri Pohlman
Stock Analyst at BTIG
(0.65)
# 3,727
Out of 4,711 analysts
21
Total ratings
30%
Success rate
-20.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kaveri Pohlman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MGNX MacroGenics | Downgrades: Neutral | n/a | $3.18 | - | 4 | Aug 1, 2024 | |
| GMAB Genmab | Maintains: Buy | $46 → $47 | $20.31 | +131.41% | 3 | Jun 27, 2024 | |
| CGEM Cullinan Therapeutics | Maintains: Buy | $20 → $30 | $11.60 | +158.62% | 2 | Apr 17, 2024 | |
| XNCR Xencor | Maintains: Buy | $56 → $38 | $24.13 | +57.48% | 1 | Apr 16, 2024 | |
| NUVB Nuvation Bio | Upgrades: Buy | $5 | $2.68 | +86.57% | 2 | Mar 26, 2024 | |
| JANX Janux Therapeutics | Initiates: Buy | $62 | $56.83 | +9.10% | 1 | Mar 21, 2024 | |
| PYXS Pyxis Oncology | Initiates: Buy | $8 | $1.69 | +373.37% | 1 | Feb 9, 2024 | |
| EXEL Exelixis | Initiates: Buy | $27 | $33.29 | -18.89% | 1 | Dec 19, 2023 | |
| RCUS Arcus Biosciences | Reiterates: Buy | $70 | $15.50 | +351.61% | 1 | Aug 23, 2023 | |
| STTK Shattuck Labs | Initiates: Buy | $12 | $1.15 | +943.48% | 1 | Aug 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $8 | $1.09 | +633.94% | 2 | Jul 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12,320 → $4,928 | $1.56 | +315,797.44% | 2 | Feb 9, 2022 |
MacroGenics
Aug 1, 2024
Downgrades: Neutral
Price Target: n/a
Current: $3.18
Upside: -
Genmab
Jun 27, 2024
Maintains: Buy
Price Target: $46 → $47
Current: $20.31
Upside: +131.41%
Cullinan Therapeutics
Apr 17, 2024
Maintains: Buy
Price Target: $20 → $30
Current: $11.60
Upside: +158.62%
Xencor
Apr 16, 2024
Maintains: Buy
Price Target: $56 → $38
Current: $24.13
Upside: +57.48%
Nuvation Bio
Mar 26, 2024
Upgrades: Buy
Price Target: $5
Current: $2.68
Upside: +86.57%
Janux Therapeutics
Mar 21, 2024
Initiates: Buy
Price Target: $62
Current: $56.83
Upside: +9.10%
Pyxis Oncology
Feb 9, 2024
Initiates: Buy
Price Target: $8
Current: $1.69
Upside: +373.37%
Exelixis
Dec 19, 2023
Initiates: Buy
Price Target: $27
Current: $33.29
Upside: -18.89%
Arcus Biosciences
Aug 23, 2023
Reiterates: Buy
Price Target: $70
Current: $15.50
Upside: +351.61%
Shattuck Labs
Aug 31, 2022
Initiates: Buy
Price Target: $12
Current: $1.15
Upside: +943.48%
Jul 7, 2022
Maintains: Buy
Price Target: $16 → $8
Current: $1.09
Upside: +633.94%
Feb 9, 2022
Maintains: Buy
Price Target: $12,320 → $4,928
Current: $1.56
Upside: +315,797.44%